Status:
COMPLETED
Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children
Lead Sponsor:
Centre Hospitalier Intercommunal Creteil
Collaborating Sponsors:
Association Clinique Thérapeutique Infantile du val de Marne
Conditions:
Covid19
Eligibility:
All Genders
Up to 15 years
Phase:
NA
Brief Summary
This study is expected to provide, for the first time, data on Cov2-SARS circulation in asymptomatic children and children with moderate respiratory symptoms in order to construct the severity pyramid...
Detailed Description
Cov2-SARS is an emerging respiratory virus of the coronavirus family responsible for a global epidemic since November 2019. As of March 10, 2020, it had caused more than 160,000 cases of corona virus ...
Eligibility Criteria
Inclusion
- Asymptomatic children:
- Age between birth and 15 years
- Carrying out a visit within the framework defined by the learned societies and professional organisations representative of paediatrics in France, i.e. :
- The consultation of the first month and all consultations involving compulsory vaccinations (2, 4, 5, 11, 12, 16 months).
- Consultations for acute pathologies, infectious or not.
- Monitoring of chronic diseases that warrant clinical examination (the majority of which can be carried out by telemedicine) or in the case of acute exacerbation.
- In one of the participating outpatient centres
- During the study period
- With a clinical examination that does not reveal any progressive infectious pathology
- AND Pauci-symptomatic children
- Age between birth and 15 years,
- Consultant at one of the participating outpatient centres
- During the study period
- And presenting with a mild respiratory infection:
- Rhinopharyngitis, Acute otitis media, Angina, Bronchitis, etc.
- Acceptance to participate in the protocol by one of the holders of parental authority
- Affiliated to a social security
Exclusion
- Refusal to participate in the study
Key Trial Info
Start Date :
April 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
605 Patients enrolled
Trial Details
Trial ID
NCT04318431
Start Date
April 14 2020
End Date
June 1 2020
Last Update
July 9 2020
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabinet du Dr Belaroussi
Boulogne, France, 92100
2
Cabinet du Dr Derkx
Champigny-sur-Marne, France, 94500
3
Cabinet du Dr Coicadan
Chennevières-sur-Marne, France, 94430
4
14 Av rené Samuel
Clamart, France, 92140